Jul 13, 2026 08:00AM
Jul 13, 2026 08:00AM
May 7, 2026 04:05PM
Apr 16, 2026 06:02AM
Apr 16, 2026 06:00AM
Apr 14, 2026 04:05PM
Apr 14, 2026 04:05PM Aligos Therapeutics Announces First Interim Analysis Results from the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium in Participants with Chronic Hepatitis B Virus Infection and Grant of FDA Fast Tra
Jan 21, 2026 08:00AM
Jan 21, 2026 08:00AM
Oct 16, 2025 08:34AM
Oct 16, 2025 08:30AM
Aug 13, 2025 08:30AM
Aug 13, 2025 08:30AM
May 6, 2025 08:00AM Aligos Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
Mar 12, 2025 06:41AM
Nov 6, 2024 04:05PM
Oct 22, 2024 08:00AM
Sep 24, 2024 07:52AM
Sep 12, 2024 07:40AM
Jul 19, 2024 02:34PM
Jun 6, 2024 07:47AM Piper Sandler Reiterates Overweight Rating on Aligos Therapeutics Inc. (ALGS)
May 28, 2024 09:30AM
May 28, 2024 09:30AM
Nov 2, 2023 04:05PM
Sep 21, 2023 07:34AM
Jun 22, 2022 08:04AM
Jun 22, 2022 08:00AM
Jun 22, 2022 08:00AM Aligos Therapeutics Presents 28-Day Safety, Efficacy and Pharmacokinetic Clinical Data for CAM Drug Candidate ALG-000184, First Clinical Data for NASH Drug Candidate ALG-055009 and Nonclinical Data i
Jun 29, 2021 09:27AM

326,549 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All